NCT01323829View on ClinicalTrials.gov

EMG Guided Botulinum Toxin Type A Injections for Refractory High Tone Pelvic Floor Dysfunction

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

July 31, 2013

Study Completion Date

December 31, 2013

Conditions
High Tone Pelvic Floor Dysfunction
Interventions
OTHER

EMG Guidance of Injection

The use of the EMG guidance is the experimental part of the study. We will perform EMG Needle testing in order to pin-point the best location for the patients Botox injections.

Trial Locations (1)

19107

Pelvic and Sexual Health Institute, Philadelphia

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Pelvic and Sexual Health Institute

OTHER

NCT01323829 - EMG Guided Botulinum Toxin Type A Injections for Refractory High Tone Pelvic Floor Dysfunction | Biotech Hunter | Biotech Hunter